These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3838675)

  • 1. Variability of caffeine metabolism in humans.
    Kalow W
    Arzneimittelforschung; 1985; 35(1A):319-24. PubMed ID: 3838675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
    Vincent-Viry M; Pontes ZB; Gueguen R; Galteau MM; Siest G
    Genet Epidemiol; 1994; 11(2):115-29. PubMed ID: 8013893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic differences in reactions to drugs and xenobiotics. Caffeine and other drugs.
    Kalow W
    Prog Clin Biol Res; 1986; 214():331-41. PubMed ID: 3523511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylation phenotypes and biological variation in a French Caucasian population.
    Pontes ZB; Vincent-Viry M; Gueguen R; Galteau MM; Siest G
    Eur J Clin Chem Clin Biochem; 1993 Feb; 31(2):59-68. PubMed ID: 8467011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism.
    Benowitz NL; Peng M; Jacob P
    Clin Pharmacol Ther; 2003 Nov; 74(5):468-74. PubMed ID: 14586387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.
    McQuilkin SH; Nierenberg DW; Bresnick E
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):139-46. PubMed ID: 7742721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of urinary caffeine metabolites to assess biotransformation enzyme activities by reversed-phase high-performance liquid chromatography.
    Krul C; Hageman G
    J Chromatogr B Biomed Sci Appl; 1998 May; 709(1):27-34. PubMed ID: 9653923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
    Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans.
    Rasmussen BB; Brøsen K
    Ther Drug Monit; 1996 Jun; 18(3):254-62. PubMed ID: 8738764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
    William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
    Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative metabolic disposition of [1-Me14C]caffeine in rats, mice, and Chinese hamsters.
    Arnaud MJ
    Drug Metab Dispos; 1985; 13(4):471-8. PubMed ID: 2863113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between metabolic phenotype of N-acetylation and bladder cancer.
    Cui X; Guo R; Xu Z; Wang B; Li C
    Chin Med J (Engl); 2000 Apr; 113(4):303-5. PubMed ID: 11775223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine.
    Lelo A; Kjellen G; Birkett DJ; Miners JO
    J Pharmacol Exp Ther; 1989 Jan; 248(1):315-9. PubMed ID: 2913277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human disposition and some biochemical aspects of methylxanthines.
    Yesair DW; Branfman AR; Callahan MM
    Prog Clin Biol Res; 1984; 158():215-33. PubMed ID: 6396646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of caffeine and its metabolites in man.
    Tang-Liu DD; Williams RL; Riegelman S
    J Pharmacol Exp Ther; 1983 Jan; 224(1):180-5. PubMed ID: 6848742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminopyrine metabolism in man: the acetylation of aminoantipyrine cosegregates with acetylation of caffeine.
    Agúndez JA; Carrillo JA; Martínez C; Benítez J
    Ther Drug Monit; 1995 Feb; 17(1):1-5. PubMed ID: 7725368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human metabolism of [1-methyl-14C]- and [2-14C]caffeine after oral administration.
    Callahan MM; Robertson RS; Arnaud MJ; Branfman AR; McComish MF; Yesair DW
    Drug Metab Dispos; 1982; 10(4):417-23. PubMed ID: 6126344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of N-acetylation phenotyping in a Greek population using caffeine as a metabolic probe.
    Asprodini EK; Zifa E; Papageorgiou I; Benakis A
    Eur J Drug Metab Pharmacokinet; 1998; 23(4):501-6. PubMed ID: 10323334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic polymorphism of acetylation and hydroxylation in the Briton population].
    Bressollette L; Berthou F; Riche C; Mottier D; Floch HH
    Therapie; 1990; 45(2):99-103. PubMed ID: 2353336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine as a potential indicator for acetylator status.
    Rankin RB; Hudson SA; Fell AF
    J Clin Pharm Ther; 1987 Feb; 12(1):47-51. PubMed ID: 3449563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.